ATE328606T1 - Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera - Google Patents

Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Info

Publication number
ATE328606T1
ATE328606T1 AT02703130T AT02703130T ATE328606T1 AT E328606 T1 ATE328606 T1 AT E328606T1 AT 02703130 T AT02703130 T AT 02703130T AT 02703130 T AT02703130 T AT 02703130T AT E328606 T1 ATE328606 T1 AT E328606T1
Authority
AT
Austria
Prior art keywords
ulceras
treatment
peptide derivatives
chronic skin
thrombin peptide
Prior art date
Application number
AT02703130T
Other languages
English (en)
Inventor
Darrell H Carney
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Application granted granted Critical
Publication of ATE328606T1 publication Critical patent/ATE328606T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02703130T 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera ATE328606T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27

Publications (1)

Publication Number Publication Date
ATE328606T1 true ATE328606T1 (de) 2006-06-15

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703130T ATE328606T1 (de) 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Country Status (12)

Country Link
US (3) US7049294B2 (de)
EP (1) EP1414487B1 (de)
JP (1) JP4192093B2 (de)
CN (1) CN100509055C (de)
AT (1) ATE328606T1 (de)
AU (1) AU2002236768B2 (de)
CA (1) CA2455756C (de)
DE (1) DE60212143T2 (de)
DK (1) DK1414487T3 (de)
ES (1) ES2271216T3 (de)
HK (1) HK1065719A1 (de)
WO (1) WO2003013569A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡
JP2006514822A (ja) * 2002-07-02 2006-05-18 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体
DE60313982T2 (de) * 2002-07-02 2008-01-17 Orthologic Corp., Tempe Dimere von thrombinpeptidderivaten
JP5044829B2 (ja) 2003-12-31 2012-10-10 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体のための医薬組成物
WO2007035406A1 (en) * 2005-09-16 2007-03-29 Orthologic Corp. Antibodies to complementary peptides of thrombin or portions thereof
WO2008124172A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for chronic dermal ulcers
US20110105400A1 (en) * 2008-03-26 2011-05-05 Orthologic Corp. Methods for treating acute myocardial infarction
WO2009120307A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
WO2009120300A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating degenerative diseases
CA2722621A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
GB0916576D0 (en) 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
KR101793758B1 (ko) * 2010-02-24 2017-11-03 시네론 메디컬 리미티드 체형 교정 장치
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡

Also Published As

Publication number Publication date
US20040209819A1 (en) 2004-10-21
US7378500B2 (en) 2008-05-27
DE60212143D1 (de) 2006-07-20
DK1414487T3 (da) 2006-10-09
HK1065719A1 (en) 2005-03-24
EP1414487A2 (de) 2004-05-06
JP2004538320A (ja) 2004-12-24
US7833982B2 (en) 2010-11-16
WO2003013569A2 (en) 2003-02-20
US7049294B2 (en) 2006-05-23
CN100509055C (zh) 2009-07-08
US20060241049A1 (en) 2006-10-26
WO2003013569A3 (en) 2003-12-11
DE60212143T2 (de) 2007-04-12
AU2002236768B2 (en) 2006-06-08
CA2455756A1 (en) 2003-02-20
US20090029923A1 (en) 2009-01-29
ES2271216T3 (es) 2007-04-16
CN1556711A (zh) 2004-12-22
JP4192093B2 (ja) 2008-12-03
CA2455756C (en) 2013-04-02
EP1414487B1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE328606T1 (de) Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DE502005005659D1 (de) Verkürzte wundheilungsprozesse mittels neuartiger faservliese
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DE60101669T2 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
PT1112275E (pt) Novos inibidores heteroaromaticos da frutose-1,6-bisfosfatase
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
ATE438405T1 (de) Verwendung von peptidantagonisten des zonulin zur behandlung von diabetes
SE0003537L (sv) Hudvänligt lim
DK1397681T3 (da) Fremgangsmåde til identificering af midler til behandling af diabetes
DE60221884D1 (de) Mediziniscer verband
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE360438T1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
DE60219495D1 (de) Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten
DE50306258D1 (de) Topische verwendung von diuretika zur behandlung von schwellungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1414487

Country of ref document: EP